FTC Probing Turing For Antitrust Violations, Shkreli Says
The U.S. Federal Trade Commission is investigating Turing Pharmaceuticals Inc. for possible antitrust violations, a lawyer for indicted former CEO Martin Shkreli said Friday, in connection with the drugmaker's pricing decisions...To view the full article, register now.
Already a subscriber? Click here to view full article